BREAKING: Per the OFA, they have LOST their lawsuit against the FDA and Eli Lilly over compound Tirzepatide
In a stunning move, Texas District Court Judge Mark Pittman has ruled in favor of the FDA and Eli Lilly in the Tirzepatide lawsuit.
This is a developing story. More to come.
That's a massive blow for anyone relying on https://ways2well.com/blog/stem-cell-for-scoliosis-innovative-treatments-for-spinal-health compounded tirzepatide—I know so many people who couldn't afford the name-brand version and turned to compounders as their only option. Judge Pittman's ruling essentially backs the FDA's decision to take tirzepatide off the shortage list, which shuts down that legal avenue for compounding pharmacies. I'm honestly worried about what this means for patients who've been stable on these alternatives; the price jump back to Eli Lilly's product is going to be brutal for a lot of folks. Definitely a developing story worth keeping an eye on.